Novabay Pharmaceuticals Inc Institutional ownership
What is the Institutional ownership of Novabay Pharmaceuticals Inc?
The Institutional ownership of Novabay Pharmaceuticals Inc is 2.57%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NYSEMKT compared to Novabay Pharmaceuticals Inc
What does Novabay Pharmaceuticals Inc do?
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the dermatology market; and aganocide® compounds, led by auriclosene™. novabay is commercializing avenova, a prescription lid and lash hygiene product for the management of the chronic eye conditions of blepharitis and meibomian gland dysfunction – also known as dry eye syndrome. these difficult-to-manage conditions affect approximately 30 million americans, with an annual market potential that novabay estimates at $500 million. novabay is gaining market traction with avenova through its 35-medical direct sales representatives under veteran leadership. avenova is available for order in 90% of all pharmacies across
Companies with institutional ownership similar to Novabay Pharmaceuticals Inc
- M.R.M. SA has Institutional ownership of 2.56%
- TINC Comm. VA has Institutional ownership of 2.56%
- Outcrop Gold has Institutional ownership of 2.56%
- iDreamSky Technology has Institutional ownership of 2.56%
- Jaiprakash Power Ventures has Institutional ownership of 2.57%
- Gocl L has Institutional ownership of 2.57%
- Novabay Pharmaceuticals Inc has Institutional ownership of 2.57%
- Kaya has Institutional ownership of 2.57%
- Union Financière de France Banque SA has Institutional ownership of 2.57%
- POET Technologies has Institutional ownership of 2.57%
- iShares ETF (CH) - iShares Core SPI (CH) has Institutional ownership of 2.57%
- Stanley Furniture has Institutional ownership of 2.57%
- River City Bank has Institutional ownership of 2.58%